Development of a m6A- and ferroptosis-related LncRNA signature for forecasting prognosis and treatment response in cervical cancer. Wen K, Wang L, Su H, Yu L, et al. BMC Cancer 2025;25:580.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wen K, Wang L, Su H, Yu L, et al. Development of a m6A- and ferroptosis-related LncRNA signature for forecasting prognosis and treatment response in cervical cancer. BMC Cancer 2025;25:580.
PMID: 40165108